{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 293,
  "pageCount": 415,
  "prevPage": 292,
  "nextPage": 294,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes and Q&A transcripts to undermine the credibility of the drug's launch prospects.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/293",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-293",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I don't think anyone would say 'Whoa, we got to get these patients on this drug...look what it can do...a lot of people are taking a hands-off, let's just see...I haven't heard from people with much enthusiasm.'",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ae-fe09d82f91cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.85,
        "x": 0.07,
        "y": 0.4
      },
      "kind": "list",
      "text": "Saw no success with Vykat and eventually moved on to other trials\nNo Vykat enthusiasm among doctors\nExpects to rapidly hear skepticism in the field toward Vykat, given long history of PWS drug failures",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "564a070d-e024-41a5-9eb0-df67f1e38054",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "When we asked if the launch is a dud, he stated that he expects to rapidly hear skepticism in the field within 3 to 6 months, toward the drug; and that it will be the next in a long line of duds in the PWS field – “I wasn’t seeing a lot of success with the drug”; I don’t think anyone would say ‘Whoa, we got to get these patients on this drug…look what it can do…a lot of people are taking a hands-off, let’s just see…I haven’t heard from people with much enthusiasm.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2a6bce6-81da-434c-b2a0-edf8ace43efc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I wasn't seeing a lot of success with the drug and, therefore, when I had a new trial, because I'm involved like these phone calls, lots of times, as a key opinion leader, international leader in Prader-Willi Syndrome, there were some other trials that were coming down the pipeline that seemed promising.... — Trial investigator and physician; one of the leading KOL's in the PWS field",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2af-0288b1d601ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82074263-3e5c-49a3-947d-8b9a0579ba52",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Trial investigator #1 indicated that other trial investigators and PWS specialists more broadly share his negative opinion of Vykat and that there is no enthusiasm about the launch.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cd999c9-ac2f-4a54-ac45-1aac2a35e0b2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "29a0c3a1-c011-4a2d-b388-068897263506",
      "evidence": "Uses expert testimony to contradict company narrative and expose potential failure.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}